Why a1 is worth a $1.2 billion valuation
A1’s $1 billion valuation is more than double its valuation when it went public.
The company is a leader in the development of natural health supplements.
As of March 31, the company reported $1,094 million in net revenue, up 10% from $838 million a year earlier.
But as the company continues to build its portfolio, the valuation has begun to rise.
For example, it recently reported $200 million in additional revenue from partnerships, and the company said it had signed agreements with more than 20 pharmaceutical companies to develop and market its products.
The company said that its stock price increased 7% to $2.28 in premarket trading on Tuesday.
Read moreNew York Magazine: Read our full article